EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of the effect of a single dose of morroniside on rat liver subjected to ischemia and reperfusion

Małgorzata Trocha, Aleksandra Kuzan, Paulina Nowotarska, Tomasz Piasecki, Anna Merwid-Ląd, Adam Szeląg, Marcin Magdziarz, Mirosław Sopel, Alicja Z Kucharska, Katarzyna Madziarska, Tomasz Sozański

Frontiers in Molecular Biosciences · 18.05.2026 · 13

DOI: 10.3389/fmolb.2026.1798488 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Molecular Biosciences, online erschienen am 18.05.2026. Verfasst von Małgorzata Trocha und 10 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Department of Diabetology, Faculty of Medicine, Hypertension and Internal Disease, Wroclaw Medical University, Wroclaw, Poland. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hepatic ischemia-reperfusion (IR) injury remains a major clinical problem during liver surgery and transplantation, primarily due to oxidative stress, inflammatory activation, and hepatocellular damage. Morroniside (MO), an iridoid glycoside derived from Cornus officinalis , has demonstrated anti-inflammatory, antioxidant, and antifibrotic properties in various experimental models, but its role in hepatic IR injury has not been established. This study aimed to evaluate the effect of a single dose of MO on rat liver subjected to partial ischemia and reperfusion.

Methods

Wistar rats were divided into four groups: control (C), ischemia-reperfusion without treatment (CIR), and IR treated with MO at 90 mg/kg (90MIR) or 270 mg/kg (270MIR). Hepatic injury was assessed biochemically (ALT, AST, PIIINP, antioxidant capacity, cytokine profile), histologically and immunohistochemically (Collagen III, Survivin, HIF-1α, Caspase-8, IL-6).

Results

IR induced significant hepatocellular injury, reflected by elevated aminotransferases, structural disruption, and increased pro-inflammatory cytokines. MO administration produced dose-dependent and heterogeneous effects. At 90 mg/kg, MO partially attenuated early aminotransferase elevation and reduced TNF-α and VEGF levels, suggesting initial hepatoprotective activity; however, hepatocellular damage and fibrosis markers remained elevated after 24 h. At 270 mg/kg, MO paradoxically decreased antioxidant capacity and did not suppress fibrosis or apoptosis, while only modestly reducing pro-inflammatory cytokines. Histopathological analyses confirmed pronounced liver injury in all IR groups regardless of treatment.

Discussion

In conclusion, acute pre-procedural administration of MO did not provide consistent protection against hepatic IR injury, and its effects were dose-dependent and ambiguous. Further studies with prolonged dosing regimens and extended reperfusion times are warranted to clarify MO’s hepatoprotective potential.

Schlagwörter

Stichwörter der Autor:innen

hepatic ischemia-reperfusion injuryhepatoprotectioninflammationmorronisideoxidative stress

Autor:innen und Institutionen

  • Clinical Department of Diabetology, Faculty of Medicine, Hypertension and Internal Disease, Wroclaw Medical University, Wroclaw, Poland.
  • Department of Preclinical Sciences, Pharmacology and Medical Diagnostics, Wroclaw University of Science and Technology, Wroclaw, Poland.
  • Department of Biostructure and Animal Physiology, Wroclaw University of Environmental and Life Sciences, Wroclaw, Poland.
  • Department of Epizootiology with Exotic Animal and Bird Clinic, Wroclaw University of Environmental and Life Sciences, Wroclaw, Poland.
  • Department of Pharmacology, Faculty of Medicine, Wroclaw Medical University, Wroclaw, Poland.
  • Hugo Steinhaus Center, Faculty of Pure and Applied Mathematics, Wrocław University of Science and Technology, Wroclaw, Poland.

Zitieren

APA

Trocha, M., Kuzan, A., Nowotarska, P., Piasecki, T., Merwid-Ląd, A., Szeląg, A., Magdziarz, M., Sopel, M., Kucharska, A. Z., Madziarska, K., & Sozański, T. (2026). Evaluation of the effect of a single dose of morroniside on rat liver subjected to ischemia and reperfusion. Frontiers in Molecular Biosciences, 13. https://doi.org/10.3389/fmolb.2026.1798488

Vancouver

Trocha M, Kuzan A, Nowotarska P, Piasecki T, Merwid-Ląd A, Szeląg A, et al. Evaluation of the effect of a single dose of morroniside on rat liver subjected to ischemia and reperfusion. Frontiers in Molecular Biosciences. 2026;13. doi:10.3389/fmolb.2026.1798488

BibTeX
@article{Trocha2026,
  author = {Trocha, Małgorzata and Kuzan, Aleksandra and Nowotarska, Paulina and Piasecki, Tomasz and Merwid-Ląd, Anna and Szeląg, Adam and Magdziarz, Marcin and Sopel, Mirosław and Kucharska, Alicja Z and Madziarska, Katarzyna and Sozański, Tomasz},
  title = {Evaluation of the effect of a single dose of morroniside on rat liver subjected to ischemia and reperfusion},
  journal = {Frontiers in Molecular Biosciences},
  year = {2026},
  volume = {13},
  doi = {10.3389/fmolb.2026.1798488}
}
Kostenlos starten →